Showing results (31-40 of 389) with videos related to
Sort By:
Pageof 39
Biochemical Pharmacology|July 28, 1999
Comparison of the ability of dopamine receptor agonists to inhibit forskolin-stimulated adenosine 3'5'-cyclic monophosphate (cAMP) accumulation via D2L (long isoform) and D3 receptors expressed in Chinese hamster ovary (CHO) cellsD A Hall, P G StrangeBiochemical Pharmacology|July 22, 1992
Studies on the structure of the ligand-binding site of the brain D1 dopamine receptorC M Hollis, P G StrangeBioscience Reports|November 1, 1984
The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cellsJ M Hall, P G StrangeBritish Journal of Pharmacology|June 1, 1997
Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptorsD A Hall, P G StrangeProceedings of the National Academy of Sciences of the United States of America|March 1, 1976
Receptor interactions in a signalling system: competition between ribose receptor and galactose receptor in the chemotaxis responseP G Strange, D E KoshlandNeurochemistry International|September 1, 1992
Molecular characterization of D2 dopamine-like receptors from brain and from the pituitary glandP L Chazot, P G StrangeBiochemistry|October 17, 1995
pH dependence of ligand binding to D2 dopamine receptorsU M D'Souza, P G StrangeJournal of Neurochemistry|January 1, 1993
Differences in the ligand binding properties of the short and long versions of the D2 dopamine receptorS W Castro, P G StrangeBiological Psychiatry|November 1, 1996
D2-like dopamine receptors are not detectable on human peripheral blood lymphocytesJ M Vile, P G StrangeNeuroscience Letters|October 10, 1985
Inhibition of inositol phospholipid breakdown by D2 dopamine receptors in dissociated bovine anterior pituitary cellsS H Simmonds, P G StrangePageof 39